Overall, the vascular expression of PSMA was highest in the lung cancer BMs (Figure 3F,H,J) and lowest in the melanoma BMs (Figure 3B,D), while the breast cancer BMs expressed moderate levels of PSMA (Figure 3A,C) as judged by visual evaluation. This evidence concerns the gene FOLH1 and breast carcinoma.